文献速递慢阻肺

内镜下聚合物泡沫逆转侧支通气在COPD患者支气管内活瓣肺减容术中的对照试验

Reversal of collateral ventilation using endoscopic polymer foam in COPD patients undergoing endoscopic lung volume reduction with endobronchial valves: A controlled parallel group trial.
PubMed 文献 · Respirology · 2022-08-02

本研究在重度COPD患者中评估内镜下聚合物泡沫(EPF)逆转侧支通气(CV)后行支气管内活瓣肺减容术(ELVR)的疗效,并与无CV的活瓣对照组比较。结果显示EPF组与对照组在6个月时FEV1、RV、SGRQ和6分钟步行距离均有显著改善,两组间除FEV1外无显著差异,EPF无严重不良反应,提示EPF可逆转CV并扩大适合ELVR的患者人群。

要点

  • EPF可成功逆转重度COPD患者80%-95%完整斜裂的侧支通气。
  • EPF后行EBV的6个月疗效与完整裂隙患者行EBV单用相似。
  • EPF治疗无严重不良反应,可能扩大ELVR适用人群。

核心结论

  • EPF成功逆转重度COPD患者左斜裂80%-95%完整者的侧支通气,随后行EBV的结局与完整裂隙行EBV单用者相似。
  • EPF逆转CV可能增加适合ELVR的COPD患者数量,且不良反应轻微。

研究设计与样本

  • 裂隙完整度>95%者入EBV对照组行活瓣单用;裂隙完整度80%-95%者经CHARTIS确认CV后,将EPF注入对应肺段,1个月后置入EBV。

主要发现

  • 6个月时FEV1改善:EPF组+19.7% vs EBV对照组+27.7%(p < 0.05)。
  • 6个月时RV变化:EPF组-16.2% vs EBV对照组-20.1%(p = NS)。
  • 6个月时SGRQ变化:EPF组-15.1 vs EBV对照组-16.6(p = NS)。
  • 6个月时6分钟步行距离改善:EPF组+25.8%(77.2 m) vs EBV对照组+28.4%(82.3 m)(p = NS)。
  • 裂隙缺损映射至舌叶者结局优于其他肺段(FEV1 +22.9% vs +16.3%,p < 0.05)。

关键数值与推荐

  • 裂隙完整度>95%者入EBV对照组行活瓣单用;裂隙完整度80%-95%者经CHARTIS确认CV后接受EPF。
  • EPF组在EPF后1个月置入EBV。
  • EPF无严重不良反应。

临床怎么用

  • 对左斜裂80%-95%完整且目标左上叶的重度COPD患者,可考虑EPF逆转CV后行EBV肺减容。
  • 裂隙缺损位于舌叶者可能从EPF后EBV治疗中获益更明显。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: We have previously described reversal of collateral ventilation (CV) in a severe chronic obstructive pulmonary disease (COPD) patient with endoscopic polymer foam (EPF), prior to endoscopic lung volume reduction (ELVR) with valves. The aim of this study was to investigate the efficacy of this in a larger cohort and compare outcomes with a similar cohort with no CV. METHODS: Patients with severe COPD, with the left upper lobe (LUL) targeted for ELVR, were assessed for CV with high resolution computed tomography (HRCT). If fissure completeness was >95% they were enrolled as controls for valves alone (endobronchial valve control group [EBV-CTRL]). If fissure completeness was 80%-95%, defects were mapped to the corresponding segment, where EPF was instilled following confirmation of CV with CHARTIS. EBVs were inserted 1 month afterwards. RESULTS: Fourteen patients were enrolled into both arms. After 6 months, there were significant improvements in both groups in forced expiratory volume in 1 s (FEV1; +19.7% EPF vs. +27.7% EBV-CTRL, p < 0.05); residual volume (RV; -16.2% EPF vs. -20.1% EBV-CTRL, p = NS); SGRQ (-15.1 EPF vs. -16.6 EBV-CTRL p = NS) and 6 min walk (+25.8% EPF [77.2 m] vs. +28.4% [82.3 m] EBV-CTRL p = NS). Patients with fissural defects mapped to the lingula had better outcomes than those mapped to other segments (FEV1 +22.9% vs. +16.3% p < 0.05). There were no serious adverse reactions to EPF. CONCLUSION: EPF successfully reverses CV in severe COPD patients with a left oblique fissure that is 80%-95% complete. Following EBV, outcomes are similar to patients with complete fissures undergoing ELVR with EBV alone. EPF therapy to reverse CV potentially increases the number of COPD patients suitable for ELVR with minimal adverse reactions.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Ing AJ, Jayapadman A, Kim WV, et al. Reversal of collateral ventilation using endoscopic polymer foam in COPD patients undergoing endoscopic lung volume reduction with endobronchial valves: A controlled parallel group trial. Respirology. 2022. PMID: 35918295. doi:10.1111/resp.14338

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。